Dennis Freire

Director, HCP & FF Data Stewardship and Reporting Lead

East Northport, New York
516-835-4649
dennis.freire@pfizer.com

linkedin.com/in/DennisFreire

Work Experience

Jan 2024Present

Director T/L, US Specialty & LATAM Data Stewardship & Reporting

Pfizer Inc. (Commercial Analytics)

MDM Release 2 for BR, MX, AR-. Providing a single course of truth about customers across LATAM.
SMART International: Harmonize CFC reporting KPIs and reporting across IDM and EM.
U.S. SMART: Standardize the current five (5) SMART solutions present in the U.S. into one overarching unified solution across BUs, while still allowing flexibility for BU-specific needs.
EDGE: Commercial and Medical Executive Reporting. leadership KPIs and reporting at Regional, Country, BU, and Brand.
SMART Discovery: Establish a flexible data model to support ad-hoc reporting and self-service.
Dynamic Targeting: Improve Sales force effectiveness by leveraging advanced analytics to deliver targeted engagement suggestions to the field- Right HCP, Message, Channel, Frequency. Determine the optimal engagement plan based on 100+ metadata contributions.
Next Best Action (NBA) CFC Orchestration: Increased data driven decision-making for CFCs by providing them with AI/ML generated insights and suggestions.

Sep 2021Dec 2023

HCP & FF Data Stewardship & Reporting Lead for U.S. I&I, U.S. RD, and LATAM)

Pfizer Inc. (BioPharma Ops- Patient & HCP Marketing Enablement)

Defined Global, Regional and Local HCP/FF reporting strategies, playbooks, & delivery services.
Designed Global KPIs to measure and surveil innovative BM3.3. technology capabilities, new customer-facing roles, and overall Omnichannel program impact and outcomes.
Implemented a Social two-way communication model (WhatsApp Business) in LATAM.
Launched industry leading Customer Facing reporting tools to enable better customer engagement and outcomes (SMART, VeevaLink, Fit-For-Role, Channel Performance KPIs).
Established a global Customer MDM BAU and governance process, a standard Customer Data Quality Dashboard, and an efficient Data Change Request (DCR) LATAM workflow with IQVIA.

Nov 2016Sep 2021

Director T/L, Transparency North America

Pfizer Inc. (Worldwide Medical Operations, Information & Transparency)

Led a matrixed global team of 16+ colleagues in the U.S., LATAM, and APAC 'COE' to deliver on HCP/HCO payment reporting obligations for U.S., CA, LATAM, & JP Transparency laws.
Collectively responsible for monitoring, interpreting, and operationalizing evolving legislative policies, and establishing strategic, harmonized data collection and reporting solutions on a global enterprise-wide scale with cross-functional stakeholder buy-in.
Accountable for Pfizer's Transaction Repository System, an aggregate spend suite designed for HCP/ HCO data capture, stewardship, quality control and reporting in 35+ markets.
Re-designed Pfizer's Financial Disclosure operating model to meet new FDA submission & monitoring standards /timelines; accelerated for our COVID-19 EUA & BLA submissions.
Strategic analytics partner to Corporate Compliance, MAPP, Finance, Biopharma Operations, Legal, and Corporate Affairs surrounding HCP/ HCO interactions.
Enterprise-level strategy for Pfizer's MDM data, technology, and processes to enable cross-domain analytics, reduce data governance through AI/ML, and to drive change management.
Partnered w/ Digital to strengthen enterprise & local systems (SAP, ARIBA, Greenphire, MAPP, CVENT, Centris, PT&E, Cybergrants) to address changing transparency requirements.
Industry leader who collaborated with CMS, external counsel (K&S), and PhRMA to shape future Sunshine policy updates and influence Open Payments system requirements.

Dec 2015Nov 2016

Senior Manager

Pfizer Inc. (Medical Quality Assurance (MQA) Analytics and Reporting Lead)

Provided strategic & analytic support to +100 MQA Auditors in the areas of Vendor Quality, GLP Quality, R&D Portfolio/ Submission Quality, GCP adherence, & Pfizer Country Office Quality.
Developed risk-based forecasting models & resource allocation tools for GCP Site Audits.
Consulted investments in reporting and QMS technologies to establish a strong framework to identify & mitigate risks, monitor CAPAs/ remediation, and oversee Audit lifecycles.
Supported metrics and KPIs for Pfizer's Quality & Compliance Committee (QCC), Executive Compliance Committee (ECC) and the Board of Directors/ ELT.

Apr 2013Dec 2015

Associate Director

Pfizer Inc. (Financial Disclosure)

Responsible for the collection and disclosure of Clinical Investigator financial interests and arrangements to the FDA as part of Pfizer's marketing applications.
Established a global 'payment search' infrastructure that elevated insights into Pfizer's financial relationships with Clinical Investigators mitigating bias within clinical studies.
Deployed an electronic FD collection platform, Firecrest, reducing costs & resources while establishing 'near time' monitoring for Pfizer and External CRO study teams.
Collaborated with Transcelerate Member Companies, investigator sites, CROs and regulatory agencies to simplify clinical trial processes by creating a common industry FD template.

Mar 2010Apr 2013

Senior Associate

Pfizer Inc. (Data Strategy & Reconciliation)

Delivered a centralized, innovative, & cost-effective data stewardship model for customer facing interactions (meals, educational items, Speaker Program expenses, ET&M)
Innovations delivered over $2M in cost savings and improved data reconciliation activities.
- Simplified the T&E experience for colleagues through changes in policy, streamlined data entry & optimized utilization to reduce administrative efforts.
- Streamlined the Transparency in Grants Process through InterAct enhancements & integration.
Supported the filing and reporting related to Transparency in Grants (TIG) and State Law Transparency & Gift Ban initiatives.

Oct 2009Mar 2010

Transparency Coordinator

Pfizer Inc. (Transparency)

Partnered with stakeholders to pioneer system & policy developments (due to a CIA) to establish a multi-year roadmap for data stewardship, monitoring, & reporting of HCP payments.
Negotiated the integration of Pfizer's HCP Customer MDM into key FF applications.

Mar 2008Oct 2009

Marketing Review Committee (RC) Coordinator

Pfizer Inc. (Spiriva/ Viagra Marketing Teams)

Assisted with the launch of iCUE Wave 1 (FF Physician detailing application)
Outlined adoption/ utilization KPIs to ensure voucher program investments were maximized.
Delivered a RC electronic approval system (TEMPO RC).
Developed "Viagra’s Adverting & Promotional RC Guidelines" which served as the enterprise model in establishing efficiency & standardization for on-boarding new marketing agencies.

Oct 2007Mar 2008

Project Manager – Merck Product Launch

GSW-Worldwide-Gerbig Snell/ Weishemier

Strategic consultant for multiple global and market-specific product launch activities.
Budgeted/ tracked marketing job estimates; reviewed financials regularly with client and account leads; negotiated and managed project timelines.

May 2006Oct 2007

Promotional Marketing Coordinator- Business Service and Analytics

All Things Traffic- Pfizer Inc.

Enabled the implementation, quality oversight and monitoring procedures for efficient and effective logistics management of Pfizer's content from production to distribution/ consumption.
Collaborated with Distribution Managers and FF to launch PROMOS, a system used to regulate the outflow of promotional items.

Education

20062009

Masters in Business Administration (MBA)

Long Island University - C.W. Post

20022006

B.S. Degree in Chemistry - Certified by ACS

Duke University

Additional Courses

Columbia University- Business School Executive Education- Certification in Digital Health
Columbia University- Mailman School of Public Health- Masters in Health
Administration
Temple University- Regulatory Affairs and Quality Assurance Graduate
Program